A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CN1
Clinical trial NCT04418141 · COMPLETED
Trial details
- NCT number
- NCT04418141
- Sponsor
- Curon Biopharmaceutical (Australia) Co Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-02
- Primary completion
- 2021-10-07
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.